Click Therapeutics wins breakthrough nod for PDT for migraines

Click Therapeutics announced that it received FDA breakthrough device designation for its CT-132 prescription digital therapeutic (PDT).

Related Keywords

Austin Speier ,Shaheen Lakhan ,Stewart Tepper ,Geisel School Of Medicine At Dartmouth ,Dartmouth Headache Center ,Click Therapeutics ,York Based Click ,Click Neurobehavioral Intervention ,Geisel School ,Dartmouth Headache ,